Tag | Content |
---|
EnhancerAtlas ID | HS134-01076 | Organism | Homo sapiens | Tissue/cell | Mesendoderm | Coordinate | chr1:42308000-42309290 | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_25331 | chr1:42307846-42309234 | DND41 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH01I041842 | chr1 | 42307847 | 42309234 |
| Enhancer Sequence | CCCCATTGGC ACTAAAAACA GGACCCACAA AGGAGCCTCG AAGTCATGTG GAGCCAGGTT 60 TGGCAACTCA CTCCCCACTG TCCCATTACT GGCCCCTCAT AAAGGCTTCC TGATTTATCA 120 CTGCAGTAGG ACTGAACTCT TCCACCAGGA GGTTTGCTCC ATTATGCTCC ATTACTCTGG 180 CCTCATTTGA AAGCAGCCTC TGGGGCTTTA TCCATGCCAA TCAGGAGGTC TTGGTGGAAA 240 GAGCTCCACG TGCCCCTGAG ATAACAGAAT GCTAGCTTCC CACAGCTCAG ACCCACTGAG 300 AATCCTGAAG AAGGAGCCCA GCATGAGTTC ATTCTCCTTC CCAAGAGAAA AGAGAGCAGA 360 AAGAAAGAAA AGGAAGCAGC ATTCTTTCTC ATCCCTCGAG ATGGTGAAGC TCCTTTTCAT 420 TTGCTTCTGA GATCTGCAAA TCAGGTGGCA ATTTTAGCTC TTTTTGCCCC CCGCTTCTTG 480 CTAGAGTATC AGAAAGGCAC TAAGGCCAGC AGCCTCTTTC TTCATCAGCA ATTAGATCTA 540 TGGCTAGGAT CTGTCTACCT GGCACTGACC TGGGGTAACC TCAGTTCCAA TCTCTGCAGC 600 TTTCCAGAAA TGAGGCTTCA GTGTGGAGAA AGATTTTTGT TTCAAATAAA GGCTTTTCTT 660 ACGCTCAAAA GCAATGTACC CTGGAAATTG TTGCTGGGAG GACAGGAATG CAGGATGCAG 720 GCCCTCAGCT GTGAAGTCCT CCCCTCCGTT CCCCGTTACC AAGCACCTCT ACTTCCTCCC 780 TAAGACCTGA GGAAACGCTA AAAGCAGGCA CAAGCAGTAC ACAGCAAATC CCCACATTTC 840 ACGGCATATG CGCCTTCCCA GATGACTGCA TGGATACACT CCATAACACA TTGTTAAAGT 900 GATAATTAGC GATAGACTTG TTATGAATAT TCCAAATACA GTTTCTCTCT ACAACAGTTG 960 ATGGAGACAA AGGACATCAC ACGAAATGTA AGAAGTAACA GAGGGATTTT TGTGCATATA 1020 TTTTTAAAAG GTCCTGGGAA AATAGCATAA ATCAGAAGTT GATTTCAACA AATTAAACAT 1080 TTCAGGACCC ATTTCCAATG AAAGATGCAT GGGCATCAGT ATTTCCTCCG CAATGCTTAG 1140 GGAACACGCC ATCCTCCCAC AAACTCCAGT AAAGAATGTG AAACCCAATT CCAGAAGCCA 1200 CTCTTCTGTT GCCCTGTTTC ACAGCAGCTA GGAGTGCTAA AGACGGGTAG TTTAAGAAAA 1260 AAAAAAAACA GAGGAAATGC TGAGGAATAA 1290
|
| |
|
|
|